Silex Systems Limited

Silex Systems Limited

SILXY
Silex Systems LimitedUS flagOther OTC
16.64
USD
+0.95
- -
792.90MMarket Cap
Silex Systems Limited
SILXY
(Other OTC)

Recent

price

16.64

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
0.11
0.61
- -
0.57
0.01
- -
- -
- -
- -
- -
- -
- -
0.11
0.14
0.13
0.14
Revenue per Share
-0.61
-0.98
-1.08
- -
-0.87
-1.05
-0.14
-0.3
-0.13
-0.15
-0.23
-0.2
-0.24
-0.4
-0.48
-0.9
Basic EPS, GAAP
-0.56
-1.14
-0.66
-0.83
-0.01
-0.26
-0.27
-0.27
- -
- -
-0.01
-0.01
- -
- -
-0.01
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
2.42
4.66
3.29
3.96
2.44
1.38
1.8
1
0.86
0.7
0.5
0.29
1.01
3.2
2.51
1.64
Book Value per Share
1.47
3.86
2.64
3.2
2.7
1.69
2.22
1.46
1.39
1.06
0.8
0.62
1.29
3.46
2.79
1.91
Tangible Book Value per Share
29
32
34
28
34
34
24
34
34
34
34
35
39
43
47
47
Basic Weighted Avg Shares
3
19
- -
16
- -
- -
- -
- -
- -
- -
- -
- -
4
6
6
7
Sales/Revenue/Turnover
-798.66
-224.86
-46,899.17
-91.95
-21,364.15
- -
- -
- -
- -
- -
- -
- -
-106.73
-108.24
-165.58
-189.08
Operating Margin (%)
2
8
3
3
19
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Depreciation Expense
-18
-31
-37
- -
-29
-36
-3
-10
-5
-5
-8
-7
-9
-17
-23
-43
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-584.8
-161.44
-59,851.65
-0.58
-13,044.04
- -
- -
- -
- -
- -
- -
- -
-224.43
-283.65
-372.3
-626.54
Profit Margin (%)
80
142
93
88
92
57
52
42
47
36
27
22
49
145
118
82
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
1
1
1
LT Debt
75
154
119
120
92
57
54
49
47
36
27
21
51
149
132
91
Total Equity
- -
- -
- -
-12.43
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
0.04
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
-25.49
-28.43
-28.22
-0.08
-30.2
-55.22
-7.47
-26.15
-14.61
-19.46
-38.16
-51.19
-38.18
-19.63
-17.77
-43.31
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
19.94%
53.18%
-31.07%
Free Cash Flow
36.79%
16.1%
-43.49%
Net Income, GAAP
34.36%
45.39%
87.2%
Sales/Revenue/Turnover
- -
- -
11.24%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
6
2024
- -
- -
- -
- -
6
2025
- -
- -
- -
- -
7

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
-0.4
2024
- -
- -
- -
- -
-0.48
2025
- -
- -
- -
- -
-0.9

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Business
Silex Systems Limited develops and commercializes laser-based isotope separation technology, primarily through its proprietary SILEX platform, for applications in uranium enrichment, quantum silicon production, and medical isotope production; it licenses the technology to Global Laser Enrichment LLC (GLE), a majority-owned joint venture with Cameco Corporation (51%/49%), and sells cREO semiconductor technology via subsidiary Translucent Inc. The company operates in three segments: Silex Systems (Sydney, Australia), Silex USA and Translucent (North Carolina, USA), serving nuclear power utilities, quantum computing developers, and medical isotope producers across Australia, the United States, and the United Kingdom. Founded in 1987 and headquartered at Lucas Heights Science and Technology Centre in New South Wales, Australia, Silex focuses on high-value isotope enrichment markets amid growing global nuclear demand and quantum technology advancements. Recent developments include GLE achieving Technology Readiness Level 6 validation for SILEX uranium enrichment in October 2025 following large-scale pilot testing at its Wilmington facility, enabling progress toward commercial deployment at the planned Paducah Laser Enrichment Facility in Kentucky; completion of a A$130 million institutional placement and A$19.4 million Share Purchase Plan in August-September 2025 to fund commercialization through FY2028; and advancement of its Quantum Silicon (Q-Si) production module at Lucas Heights since August 2023, targeting up to 20kg annual output of silicon-28 for silicon quantum computing in partnership with Silicon Quantum Computing Pty Ltd and UNSW Sydney, which earned a Best Industry Research Collaboration award in 2025.

Company News

APIChatGPT
  • Silex Systems: Next-Gen Technology In The Uranium Industry

  • Silex Systems (OTCMKTS:SILXY) Stock Price Down 2.1% – Time to Sell?

  • Silex Systems (OTCMKTS:SILXY) Trading Down 7.4% – Here’s What Happened